Negocios · 8/8/20031 min de lectura
Clinical Studies of Safety and Effectiveness of Orphan Products; Availability of Grants; Request for Applications (Catalog of Federal Domestic Assistance No. 93.103)
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing changes to its Office of Orphan Products Development (OPD) grant program for fiscal years (FY) 2004 and 2005. This announcement supercedes the previous announcement of this program, which was published in the Federal Register of August 27, 2002 (67 FR 55020).